MTOR and COVID-19: Furthermore, mTOR pathways in conjunction with AMPK may be therapeutic targets for controlling cell injury, oxidative stress, mitochondrial dysfunction, and the onset of hyperinflammation [74], a significant disability associated with COVID-19 [75, 76].